BellaSeno is a clinical-stage medtech company advancing soft-tissue restoration through proprietary bioresorbable scaffold technology. Founded in 2017, the company operates globally with headquarters in Leipzig, Germany, and Brisbane, Australia.
Strong early clinical experience with favorable safety and encouraging tissue regeneration outcomes.
Clear regulatory pathway with ongoing Notified Body and FDA engagement and de-risked development plan.
High unmet need and platform versatility position BellaSeno for attractive partnerships and long-term value creation.
Our platform combines well-known materials, scaffold architecture, and additive manufacturing to create structured scaffolds designed to guide tissue formation over time. Using clinically established absorbable polymers and proprietary manufacturing processes, BellaSeno develops scaffolds intended to work in harmony with the body’s natural healing response, supporting the gradual formation and integration of natural tissue.
As regenerative medicine enters mainstream clinical pathways, BellaSeno’s lead clinical focus is breast surgery, where its technology is being developed to expand treatment options across reconstructive and aesthetic indications. This approach is designed to complement established surgical techniques while introducing a scaffold-guided pathway for soft-tissue restoration.
Certified under ISO 13485 and EU MDR 2017/745 standards, and supported by an advanced clinical programme, BellaSeno brings together expertise across regenerative medicine, materials science, additive manufacturing, and reconstructive surgery to help define a new category in regenerative soft-tissue solutions.
Established exclusive global distribution and strategic collaboration pathways to support future platform expansion and commercial growth.
Advancing patient enrolment and long-term outcomes generation in Primary and Revision Breast Augmentation through the ongoing BRV-005 Pivotal Clinical Trial.
Advancing scalable manufacturing capabilities through proprietary MagLev technology to support future global supply and commercial readiness.
Supporting future scalability across global markets through CE Mark achievement in resorbable soft-tissue breast applications.
Progressing toward FDA market approval in Primary and Revision Augmentation breast scaffold solutions.
Entrepreneurial medtech leader with deep expertise in regenerative biomaterials, guiding BellaSeno from scientific concept through to clinical translation, partnerships, and global commercialisation.
Clinically driven medical leader specialising in surgical application and patient outcomes, bridging clinical insight with regulatory and development strategy to ensure real-world adoption.
Advanced engineering and materials expert focused on scaffold design, additive manufacturing, and product scalability, translating complex technologies into robust, manufacturable solutions.
Strategic marketing and communications leader specialising in building category-defining brands, aligning clinical innovation with clear market narratives and global go-to-market execution.
Experienced investor and board leader with a strong track record in scaling healthcare and life sciences companies, providing strategic oversight and long-term growth guidance.
Highly respected plastic surgeon bringing extensive experience in aesthetic and reconstructive surgery, supporting clinical strategy and adoption pathways.
Renowned aesthetic surgeon and educator, contributing deep expertise in breast surgery and patient-centred outcomes to guide clinical application.
Internationally recognised leader in plastic and reconstructive surgery, providing clinical leadership and driving evidence generation through trials and research.
Surgeon and healthcare strategist combining clinical excellence with commercial and operational insight to support scalable clinical integration.
Experienced plastic surgeon with a strong focus on patient safety and outcomes, informing best practice and clinical positioning.
Globally recognised authority in breast surgery, contributing extensive clinical research experience and expertise in surgical techniques and outcomes.
Senior plastic surgeon with broad experience across aesthetic and reconstructive procedures, supporting clinical evaluation and real-world application.
Deutscher Platz 5A
04103 Leipzig
Germany
4 Starling Street
Burliegh Heads
QLD, Australia, 4220
